Validity of self-reported misuse of prescription opioid analgesics

Subst Use Misuse. 2010 Aug;45(10):1509-24. doi: 10.3109/10826081003682107.


Aim: To determine concurrent validity of self-reported misuse of prescription opioids.

Design and setting: Cross-sectional study in five U.S. methadone maintenance programs.

Participants: 92 addicts.

Measurements: Self-reported questionnaire assessing past-month misuse of 14 opioid analgesics, and color photographs of five opioid analgesics with instructions to mark those used in the past month "to get high." Concordance between self-report and photograph endorsement was assessed via Kappa statistic.

Findings: 29 respondents completed both questionnaire and photograph endorsements. Kappas were 0.62 (OxyContin), 0.59 (methadone), 0.49 (Dilaudid), and 0.46 (generic extended-release oxycodone).

Conclusions: Good-to-fair concurrent validity of self-reported abuse was seen for OxyContin, methadone, Dilaudid, and generic extended-release oxycodone.

Publication types

  • Validation Study

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Analgesics, Opioid / therapeutic use*
  • Cross-Sectional Studies
  • Female
  • Humans
  • Male
  • Middle Aged
  • Prescription Drugs / therapeutic use*
  • Self Disclosure
  • Substance-Related Disorders / epidemiology*
  • Surveys and Questionnaires / standards*
  • United States / epidemiology
  • Young Adult


  • Analgesics, Opioid
  • Prescription Drugs